YolTech raises $70.0M (China, May 2026)
$70.0M
$70MGenerated social card
Headline
Exclusive: China gene editing startup YolTech raises $70M to move CRISPR therapies forward - Endpoints News
About
YolTech is a gene editing startup focused on advancing CRISPR therapies. The company aims to develop innovative treatments in the field of genetic medicine and is preparing for a public offering in Hong Kong.
Article summary
Exclusive: China gene editing startup YolTech raises $70M to move CRISPR therapies forward Endpoints News
Founder
Yuxuan Wu
CEO
Investors
Related rounds
| Jun 10, 2026 | Ant International | $1.00B | — | China |
| Jun 08, 2026 | Moonshot AI | $2.00B | — | China |
| Jun 08, 2026 | SunUp Fusion | $100.0M | — | China |
| Jun 01, 2026 | Gen-Z gamer's 3D-model startup | $200.0M | — | China |